Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSD (CPTDBT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02574429
Recruitment Status : Completed
First Posted : October 12, 2015
Last Update Posted : December 18, 2018
Sponsor:
Information provided by (Responsible Party):
St. Joseph's Healthcare Hamilton

Brief Summary:
Even though borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD) commonly co-occur, few studies have examined PTSD treatment among individuals with BPD. Additionally, many PTSD research studies exclude individuals with BPD due to their complexity and concerns regarding risk. This study aims to investigate the effectiveness of Cognitive-Processing Therapy Group (an evidenced-based treatment for PTSD) for individuals with these co-occurring disorders following completion of a Dialectical Behavioural Therapy Program (an evidenced-based treatment for BPD). The investigators are using a repeated measures pre and post design. Data will be collected prior to participants starting the CPT group, throughout the duration of the CPT group (i.e., weekly), and following the completion of the CPT group.

Condition or disease Intervention/treatment Phase
Borderline Personality Disorder Posttraumatic Stress Disorder Behavioral: Cognitive Processing Therapy Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Pilot Study Examining the Impact of a Cognitive Processing Therapy (CPT) Group for Patients With Co-Occurring Borderline Personality Disorder and Posttraumatic Stress Disorder
Study Start Date : April 2016
Actual Primary Completion Date : December 2018
Actual Study Completion Date : December 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Cognitive Processing Therapy
Individuals who have either completed Standard Dialectical Behavior Therapy (DBT) for Borderline Personality Disorder (BPD) and/or are currently enrolled in DBT who have co-occuring PTSD.
Behavioral: Cognitive Processing Therapy
Cognitive Processing Therapy is an evidenced-based treatment for PTSD. The investigators are offering CPT group over 13 weeks (12 group sessions & 1 individual session). CPT focuses on challenging beliefs that developed or were reinforced following the trauma(s).
Other Name: CPT




Primary Outcome Measures :
  1. Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) [ Time Frame: Weekly for 13 weeks (course of treatment) ]
    Self-report measure assessing change in PTSD DSM-5 symptoms are affecting the participant. The investigators are comparing pre-PCL scores to post-PCL scores. In addition, the investigators are interested in examing the pattern of change between sessions.


Secondary Outcome Measures :
  1. BSL-23 [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing the presence of BPD symptoms (experiences and behaviors)

  2. Ways of Coping Checklist (WCCL) [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-reported use of DBT skills use vs. less effective ways of coping

  3. Depression, Anxiety, Stress and Suicide Scale (DASS-21) [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing symptoms of depression, anxiety, stress and suicide.

  4. Difficulties in Emotion Regulation Scale (DERS) [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing how the individual expresses and copes with emotions

  5. Experience of Shame Scale [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing the extent that an individual experienced shame

  6. Anxiety Sensitivity Index (ASI-3) [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing the extent to which an individual is sensitive to anxiety cues

  7. Self-compassion Scale (SCS) [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing the extent to which an individual treats his or herself self-compassionately.

  8. The Life Events Checklist for DSM-5 (LEC-5) [ Time Frame: Baseline only ]
    Self-reported description of the nature of the traumatic experience(s) the individual experienced.

  9. Borderline Evaluation of Severity Overtime (BEST) [ Time Frame: 2 times - once prior to starting treatment, and once at the end of 13 weeks of treatment ]
    Self-report measure assessing the presence of BPD symptoms (experiences and behaviors)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   17 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individuals diagnosed with co-occurring BPD/PTSD who are either currently participating in Standard Dialectical Behaviour Therapy (DBT) or who have completed DBT

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02574429


Locations
Layout table for location information
Canada, Ontario
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 3K7
St Joseph's Healthcare Hamilton, Community Psychiatry Clinic
Hamilton, Ontario, Canada, L8N3K7
Sponsors and Collaborators
St. Joseph's Healthcare Hamilton

Layout table for additonal information
Responsible Party: St. Joseph's Healthcare Hamilton
ClinicalTrials.gov Identifier: NCT02574429     History of Changes
Other Study ID Numbers: CPTDBT-1
First Posted: October 12, 2015    Key Record Dates
Last Update Posted: December 18, 2018
Last Verified: December 2018

Keywords provided by St. Joseph's Healthcare Hamilton:
Borderline Personality Disorder
Posttraumatic Stress Disorder
Cognitive Processing Therapy
Group Therapy
Comorbidity
Dialectical Behavior Therapy

Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Personality Disorders
Borderline Personality Disorder
Pathologic Processes
Trauma and Stressor Related Disorders
Mental Disorders